Sizmek Announces Strategic Partnership with Yahoo! JAPAN for the Japanese Market
Nov 02, 2016 12:41 pm UTC| Business
AUSTIN, Texas, Nov. 02, 2016 -- Sizmek, an open ad management platform for multiscreen ad experiences, today announced a strategic partnership with Yahoo! JAPAN. Through the partnership, Yahoo! JAPAN will become the...
Huntington Ingalls Industries Increases Quarterly Dividend to $0.60 per Share
Nov 02, 2016 12:31 pm UTC| Business
NEWPORT NEWS, Va., Nov. 02, 2016 -- Huntington Ingalls Industries (NYSE:HII) announced today that its Board of Directors has declared a quarterly cash dividend of $0.60 per share, a 20 percent increase over the $0.50...
Huntington Ingalls Industries Increases Quarterly Dividend to $0.60 per Share
Nov 02, 2016 12:31 pm UTC| Business
NEWPORT NEWS, Va., Nov. 02, 2016 -- Huntington Ingalls Industries (NYSE:HII) announced today that its Board of Directors has declared a quarterly cash dividend of $0.60 per share, a 20 percent increase over the $0.50...
Retail TouchPoints Announces 2016 Store Operations Superstar Awards
Nov 02, 2016 12:31 pm UTC| Business
HASBROUCK HEIGHTS, N.J., Nov. 02, 2016 -- Retail TouchPoints, the industry’s go-to source for customer engagement strategies, today announced the winners of its Store Operations Superstar Awards, recognizing 10...
Retail TouchPoints Announces 2016 Store Operations Superstar Awards
Nov 02, 2016 12:31 pm UTC| Business
HASBROUCK HEIGHTS, N.J., Nov. 02, 2016 -- Retail TouchPoints, the industry’s go-to source for customer engagement strategies, today announced the winners of its Store Operations Superstar Awards, recognizing 10...
Corvus Pharmaceuticals to Present at SITC’s 31st Annual Meeting
Nov 02, 2016 12:31 pm UTC| Business
BURLINGAME, Calif., Nov. 02, 2016 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today...
Corvus Pharmaceuticals to Present at SITC’s 31st Annual Meeting
Nov 02, 2016 12:31 pm UTC| Business
BURLINGAME, Calif., Nov. 02, 2016 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today...